145 results on '"Tufman, Amanda"'
Search Results
2. Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade
3. Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies
4. Extracorporeal Photopheresis as a Treatment Option for Immune-Related Adverse Events: Two Case Reports and a Prospective Study
5. Herausgeber
6. Pneumologie
7. First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations
8. Tumor seeding following CT- guided transthoracic needle biopsy in lung cancer. A case report
9. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
10. Early mortality in German patients with lung cancer: risk factors associated with 30-and 60-day mortality
11. Clinical risk factors for checkpoint pneumonitis vs. other pneumonitis in lung cancer patients treated with checkpoint inhibitors
12. Endoskopische Diagnostik bei thorakalen Tumoren
13. Chemotherapy and molecular biological therapy
14. Pneumologie
15. Autorinnen und Autoren
16. Evaluation of solitary pulmonary nodules
17. Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
18. Zunehmende Luftnot und wechselnde Gelenkbeschwerden
19. Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study
20. Finger Pain as an Uncommon Primary Manifestation of Lung Carcinoma
21. Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patients
22. Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
23. Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022
24. Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers
25. 68Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
26. Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
27. Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board
28. COVID-19 in Recent Lung Transplant Recipients: Clinical Outcomes and Management Strategies
29. The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions
30. Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study
31. Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC
32. Treatment patterns and prognosis in inoperable stage III NSCLC after concurrent chemoradiotherapy with or without immune checkpoint inhibition: Historical overview.
33. Treatment patterns and outcomes in resectable early stage NSCLC: Interim analysis of a global real-world study.
34. Pattern of failure in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy with/without immune checkpoint inhibition.
35. Propensity-matched analysis of concurrent/sequential versus sequential immune checkpoint inhibition in inoperable stage III NSCLC patients treated with chemoradiotherapy.
36. The Role of Thoracic Surgery in Small Cell Lung Cancer – A Large Longitudinal Analysis (2002-2015) Based on Real-World Data
37. Patient perception of burden of disease and treatment preferences in non-small cell lung cancer: results from a European survey
38. Autorinnen und Autoren
39. Pneumologie
40. Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire
41. Thorakale Onkologie – frühe Stadien
42. Lymphocytes and sinus histiocytosis in tumor and matched lymph nodes as predictors of survival in non-small-cell lung cancer
43. Changes in Behavior After Vaccination and Opinions Toward Mask Wearing: Thoracic Oncology Patient–Reported Experiences During the COVID-19 Pandemic
44. Rare driver alterations in nonsmall cell lung cancer: novel targeted drugs
45. Novel Multimodal Management of Post-Partum Synchronous Metastatic Pulmonary EBV-Associated Lymphoepithelioma-like Carcinoma (LELC)—A Case Report
46. Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
47. Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment
48. Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
49. One-year follow-up—case report of secondary tension pneumothorax in a COVID-19 pneumonia patient
50. Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.